Leyden Laboratories
Develops broadly protective antibody-based nasal sprays to prevent infection by influenza and other respiratory viruses
€40MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops broadly protective antibody-based nasal sprays to prevent infection by influenza and other respiratory viruses